Private plans fall short on fertility coverage, first report card finds

Sixteen of 17 group insurers are graded C or D as advocates push to make fertility and family-building benefits a standard inclusion

Private plans fall short on fertility coverage, first report card finds

None of the 17 group benefits insurers assessed in Canada’s first report card on fertility and family-building coverage in private plans earned an A, and 16 of them, or 94 per cent, were graded C or D.

The Private Plan Leadership: Fertility and Family-Building Coverage Report Card 2026 was released by Fertility Matters Canada (FMC) on November 2, World Fertility Day. It was produced by Mapol Inc. in association with Selectpath Benefits & Financial Inc., with funding from EMD Serono.

The report focuses on private plans, meaning the drug and extended health benefits that employers buy from insurers to supplement public coverage. It grades each insurer on its current standard plans: the coverage the insurer would offer a new plan sponsor with no legacy plan design.

One insurer earned a B grade. Eight earned a C grade because fertility drugs are a standard inclusion, meaning they are covered unless the plan sponsor opts out, but their fertility and family-building coverage limits are below $20,000. The other eight insurers earned a D grade because fertility and family-building coverage is optional for most of their plans: either the plan sponsor must request it, or it varies by group size. The report card lists each insurer and its grade.

“We’ve seen encouraging progress, but there’s still a significant gap between what’s available and what Canadians need,” wrote Carolynn Dubé, executive director of FMC, in a LinkedIn post marking the release.

Opt-in by design

The report’s central finding is about who makes the decision. Under today’s opt-in approach, a plan sponsor and its advisor must ask for fertility coverage to be added. The report calls for the reverse: fertility coverage as a standard inclusion, already priced in, with plan sponsors free to opt out if they choose.

“When you offer something as optional, many people do not choose the option because it is perceived as nice to have,” said Johnny Ma, president of Mapol, during an October 29 webinar previewing the findings with FMC.

Plan documents show the result. In a review of 637 benefits booklets covering about 5.5 million plan member lives, Mapol found fertility drug coverage explicitly included for 38% of those lives. The most common lifetime maximum was $5,000, and just 0.6% of lives had a limit of $20,000 or more.

“The Canadian benefits system currently funds avoiding pregnancy as a standard but treats building a family as optional,” wrote Gordon R. Hart, CEO and chairman of Selectpath Benefits & Financial, in the report.

Limits well below the cost of care

A single IVF cycle in Canada costs about $15,000 to $20,000 once drug, clinic and laboratory costs are combined, according to the report, and a complete fertility journey routinely reaches $40,000 to $60,000 or more. Surrogacy typically costs $60,000 to $100,000. The report estimates that fewer than 2 per cent of the roughly 27 million Canadians with supplementary health insurance have modern fertility and family-building coverage.

Public programs cover only part of the gap. Ontario, Quebec and British Columbia fund one IVF cycle directly, although Ontario does not cover fertility medications and British Columbia’s amount depends on household income. Newfoundland and Labrador, Prince Edward Island and New Brunswick reimburse costs after treatment, while Manitoba, Saskatchewan, Nova Scotia and Yukon offer refundable tax credits. Alberta, the Northwest Territories and Nunavut have no general public program.

That is where private plans come in. “Private insurance is here to supplement coverage, not to duplicate coverage, and that’s the key,” Ma said. “Where there’s a gap, there is an opportunity to support that plan member.”

The costs also land at work. A 2026 study by Fertility Alberta Advocacy & Outreach Association and Mount Royal University, cited in the report, surveyed 206 Albertans who had pursued fertility treatment. Respondents spent an average of $35,000 out of pocket, 82% took time off work for treatment, and only 21.2% had any employer fertility benefit.

Dubé pointed to employees who live far from a fertility clinic.

“If you’re in Gander, Newfoundland, you have to get on an airplane and fly to another province, and then how do you have that conversation with your employer when you’re a nurse or an educator?" said Dubé. 

What good looks like

To earn an A, an insurer’s current standard plans must include a combined family-building benefit of at least $50,000 per family lifetime, covering fertility medications, fertility procedures and preservation, and donor, surrogacy and adoption costs, usable across categories as the plan member needs.

The report bases that threshold on a published insurer recommendation of at least $15,000 and up to $50,000 per family, the cost of a typical journey to a live birth, and the plans some large employers already offer their own staff. TD Bank, for example, set separate $20,000 lifetime maximums for fertility and reproductive treatments, for surrogacy and donor costs, and for adoption, on top of its existing fertility drug coverage, for at least $60,000 in total.

Ma noted that large employers can negotiate plan designs like these, while smaller employers generally rely on what the insurer’s current standard plans include.

“Why should your ability to have a family differ if you work for a small employer versus a large employer?” he said.

Making it a standard inclusion

The report makes four recommendations. Insurers should make fertility medications a standard inclusion in every standard plan, with plan sponsors given the ability to opt out if they choose, and should set a combined family-building benefit of at least $50,000 per family lifetime. Coverage should extend beyond drugs to procedures and preservation, donor services, surrogacy and adoption for all plan sponsors, not only large ones. And eligibility language should not exclude single plan members, 2SLGBTQ+ families or people who need donor gametes or cannot carry a pregnancy.

Dubé said fertility and family-building coverage should be a standard inclusion in every plan. “We don’t have to opt into this; it is just baked into the plans that exist, and then employers can opt out if they so choose,” she said.

In her LinkedIn post, Dubé wrote that employers, insurers and benefits advisors “have an important role to play” in changing how financial barriers affect people’s ability to build a family. FMC plans to take the report card to benefits advisors and brokers next, and then to insurers, she said during the webinar.

“The only way to manage something is to measure it first,” Ma said. “So this is what we’re doing. We’re measuring. We’re at step one.”